학술논문

Adapting clinical guidelines in low-resources countries: a study on the guideline on the management and prevention of type 2 diabetes mellitus in Indonesia.
Document Type
Article
Source
Journal of Evaluation in Clinical Practice. Feb2017, Vol. 23 Issue 1, p121-127. 7p.
Subject
*HYPERGLYCEMIA treatment
*HYPERLIPIDEMIA treatment
*TYPE 2 diabetes diagnosis
*TYPE 2 diabetes prevention
*TYPE 2 diabetes treatment
*HYPOGLYCEMIC agents
*MEDICAL protocols
*BEHAVIOR modification
*BLOOD pressure
*BLOOD sugar
*CONSENSUS (Social sciences)
*GLYCOSYLATED hemoglobin
*HEALTH behavior
*INTERVIEWING
*CASE studies
*MEDICAL practice
*TYPE 2 diabetes
*QUALITY assurance
*SCALE analysis (Psychology)
*DESCRIPTIVE statistics
DEVELOPING countries
Language
ISSN
1356-1294
Abstract
Rationale, aims and objectives Most of the clinical guidelines in low-resource countries are adaptations from preexisting international guidelines. This adaptation can be problematic when those international guidelines are not based on current evidence or original evidence-based international guidelines are not followed. This study aims to evaluate the quality of an Indonesian type 2 diabetes mellitus guideline adapted from selected international guidelines. Methods The 'Consensus on the Management and Prevention of type 2 Diabetes in Indonesia 2011' is a guideline by the Indonesian Society of Endocrinology (Perkeni). Four parent guidelines identified from its list of references were from the International Diabetes Federation (IDF), American Association of Clinical Endocrinologist (AACE), American Diabetes Association (ADA), and one jointly released by ADA and European Association for the Study of Diabetes (EASD). Two reviewers independently assessed its quality using the Appraisal of Guidelines, Research and Evaluation Collaboration (AGREE II) instrument. Six recommendations were compared: (1) screening for diabetes; (2) diagnosis; (3) control of hyperglycemia; (4) target blood glucose; (5) target blood pressure; and (6) treatment of dyslipidemia. Results Perkeni's guideline satisfied 55% of the AGREE II items, while its parent guidelines satisfied 59% to 74%. Perkeni's shows low score on 'rigor of development' and 'applicability' and the lowest score in the 'scope and purpose' domain. Differences were found in 4 recommendations: the screening of diabetes, control of hyperglycemia, target blood glucose, and treatment of dyslipidemia. In 3 of 4, Perkeni followed the ADA's recommendation. Conclusion Derivation of recommendations from parent guidelines and their adaptation to the context of Indonesian health care lacks transparency. When guidelines are either derived from other guidelines or adapted for use in different context, evidence-based practice principles should be followed and adhered to. [ABSTRACT FROM AUTHOR]